Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Reproductive BioMedicine Online Année : 2021

Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids

Résumé

Research question: What is the evolution of adenomyosis on magnetic resonance imaging (MRI) after a 3-month treatment course of daily 5 mg doses of ulipristal acetate (UPA) for symptomatic fibroids? Design: A monocentric prospective pilot study on patients who underwent a 3-month treatment course of UPA for symptomatic fibroids between January 2014 and December 2017. Patients underwent pelvic MRI shortly before (pre-MRI) and after treatment (post-MRI). The diagnosis of adenomyosis on MRI was defined by the observation of intramyometrial cysts and/or haemorrhagic foci within these cystic cavities and/or a thickening of the junctional zone >12 mm. The progression of adenomyosis was defined by the presence of at least one of the aforementioned criteria of adenomyosis on the pre-MRI and by at least one of the following on the post-MRI: (i) increased thickness of the junctional zone ≥20% and/or (ii) increased number of intramyometrial cysts. The appearance of adenomyosis was defined by the absence of the aforementioned criteria of adenomyosis on the pre-MRI and the presence of at least one of these criteria on the post-MRI. Results: Seventy-two patients were included. The MRI features of adenomyosis progressed for 12 of 15 patients (80.0%) for whom adenomyosis was identified on the pre-MRI. An appearance of adenomyosis was identified after treatment for 15 of 57 patients (26.3%) for whom adenomyosis was not identified on the pre-MRI. Conclusions: A 3-month treatment course of daily 5 mg doses of UPA could provoke a short-term progression or an emergence of typical adenomyosis intramyometrial cysts on MRI examinations.
Fichier principal
Vignette du fichier
CALDERON 2021.pdf (731.52 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03216026 , version 1 (13-01-2022)

Identifiants

Citer

Lisa Calderon, Antoine Netter, Anaïs Grob-Vaillant, Julien Mancini, Pascale Siles, et al.. Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids. Reproductive BioMedicine Online, 2021, 42 (3), pp.661-668. ⟨10.1016/j.rbmo.2020.11.012⟩. ⟨hal-03216026⟩
53 Consultations
108 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More